Pfizer/BioNTech vaccine against coronavirus a week after Europe started its mass immunization campaign, the Finnish YLE broadcaster reported on Saturday.The EU member states launched the bloc-wide vaccination program on December 27, the next day after receiving their first shipments of the Pfizer/BioNTech vaccine following the European Commission's authorization."When there are at least five such reports, we will put information on our website about the type of reactions that have occurred," the agency's Chief Physician Maija Kaukonen told the broadcaster, adding that no further details could be disclosed due to patient confidentiality.At the same time, Kaukonen noted that reports of allergic or adverse reactions were likely to increase.So.